oncologywatch

Two dozen companies have compounds in clinical trials, according to PhRMA’s 2008 report: Medicines in Development for Cancer (full text available online). In the list of compounds below, I linked the names to ClinicalTrials.gov for current status of studies.

AstraZeneca (Wilmington, DE)
AZD2171 (cedironib)
Iressa (gefitinib)

AVANT Immunotherapeutics (Needham, MA)
CDX-110

Bionumerik Pharmaceuticals (San Antonio, TX)
BNP 1350

Bristol-Myers Squibb (Princeton, NJ)
CT-322

Celgene (Summit, NJ)
CC-8490
Revlimid (lenalidomide)

Genentech (South San Francisco, CA)
Avastin (bevacizumab)
Tarceva (erlotinib)

GlaxoSmithKline (Philadelphia, PA; Research Triangle Park, NC)
Armala (pazopanib)
Hycamtin (topotecan)

Johnson & Johnson Pharmaceutical Research & Development (Raritan, NJ)
Zarnestra (tipifarnib)
enzastaurin (LY 317615)

Medigene (San Diego, CA)
G 207

Merck (Whitehouse Station, NJ)
Zolinza (vorinostat)

Merck KGaA (Darmstadt, Germany)
cilengitide

Myriad Pharmaceuticals (Salt Lake City, UT)
Azixa (MPC-6827)

Neopharm (Waukegan, IL)
IL13-PE38QQR

Northwest Biotherapeutics (Buthell, WA)
DeVax - Brain

Novartis Pharmaceuticals (East Hanover, NJ)
AEE-788
gimatecan
Glivec (imatinib)
Oncolar (octreotide)
vatalanib (PTK 787)

Oncolytics Biotech (Calgary, AB)
Reolysin

Peregrine Pharmaceuticals (Tustin, CA)
Cotara (MAb TNT-1)

Pharmacyclics (Sunnyvale, CA)
Xcytrin (motexafin gadolinium)

Protherics (Brentwood, TN)
OncoGel

Reata Pharmaceuticals (Dallas, TX)
RTA 744 (berubicin)

Teva Pharmaceuticals (North Wales, PA)
talampanel

Transmolecular (Cambridge, MA)
131-1-TM-601

VION Pharmaceuticals (New Haven, CT)
laromustine (VNP 40101M)

YM Biosciences (Wayne, PA)
nimotuzumab

OncologyWatch: Posts about free-access articles on aspects of oncology theory, practice and policy (about the blogger).

Technorati tags:
oncology cancer pharmaceutical industry glioblastoma multiforme

Comments and Links Welcome!